Send the following on WhatsApp
Continue to ChatSafety and efficacy of regorafenib in patients with treatment-refractory metastatic colorectal cancer in Turkey: the single-arm, open-label REGARD study - https://avesis.akdeniz.edu.tr/yayin/ea3f08ec-0e88-4ecf-805c-95561a15f194/safety-and-efficacy-of-regorafenib-in-patients-with-treatment-refractory-metastatic-colorectal-cancer-in-turkey-the-single-arm-open-label-regard-study